Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F9BM4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,613
Award facts
- Contract value 100% obligated
- $20,612.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with a ceiling value of $20,612.86 under a firm fixed-price arrangement. The order is set to be completed by November 14, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively awarded this delivery order without set-aside designation. As the prime contractor on the underlying IDC, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's federal contracting history demonstrates its capability to manage diverse medical supply portfolios, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9BM4?
SPE2DR26F9BM4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BM4 worth?
The government has obligated $20,613 on SPE2DR26F9BM4.
Is contract SPE2DR26F9BM4 an order under another contract?
Yes. SPE2DR26F9BM4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BM4 competed?
The extent of competition for SPE2DR26F9BM4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award